Aerie Pharmaceuticals, Inc. announced the appointment of Julia Williams as Director of Medical Affairs, reporting to John Maltman, Ph.D., Aerie's Vice President of Medical Affairs. Ms. Williams will participate in directing the strategic and operational activities of the Company's Medical Affairs organization, initially focused on the launch of Rhopressa (netarsudil ophthalmic solution) 0.02%. She previously held related positions at Ora, Inc. and Allergan, Inc.